CPD Login
Versatile IDegAsp
For people with type 2 diabetes (T2DM) who fail to achieve optimal blood glucose levels with basal insulin and oral…
Long-term efficacy and safety of ruxolitinib in patients with polycythaemia vera
The results of the five year phase 3 RESPONSE study showed that ruxolitinib, a Janus kinase (JAK) 1 and 2…
TPO-RA: Game-changers in the treatment of immune thrombocytopaenia
Immune thrombocytopenia (ITP) – previously referred to as idiopathic thrombocytopenic purpura – is an autoimmune bleeding disorder characterised by abnormally low…
Weight-loss medications: how do they measure up?
As global waistlines expand, the demand for weight-loss drugs follows suit. While the US Food and Drug Administration (FDA) has…
Protected: Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency
The objective of this study was to analyze the current evidence for the use of pancreatic enzyme replacement therapy (PERT)…
SCALE-ing obesity
Obesity management is more than numbers on a scale, it is about improving health – Dr Sue Pedersen
IDegLira: Simplifying T2DM management
According to a survey by the International Diabetes Federation, the prevalence if T2DM is expected to exceed 10% of the…
The challenge of obesity in the psychiatric population
SA has the highest overweight and obesity rate in sub-Saharan Africa, with up to 70% of women and a third…
The future of healthcare is green
Dr Ted Schettler has been a staunch advocate of environmental health and justice for the past 30 years. He is…
